Alternative strategies
Carmignac Portfolio Long-Short European Equities
Share Class
LU0992627371
Risk Indicator
3 / 7
Recommended Minimum Investment Horizon
3 years
Cumulative Performance since launch
Cumulative Performance 10 YearsCumulative Performance 5 YearsCumulative Performance 3 YearsCumulative Performance 12 Months
From 15/11/2013
To 15/07/2025
+ 69.9 %
+ 61.9 %
+ 29.3 %
+ 14.3 %
+ 3.6 %
Calendar Year Performance 2015Calendar Year Performance 2016Calendar Year Performance 2017Calendar Year Performance 2018Calendar Year Performance 2019Calendar Year Performance 2020Calendar Year Performance 2021Calendar Year Performance 2022Calendar Year Performance 2023Calendar Year Performance 2024
- 8.4 %
+ 9.4 %
+ 16.5 %
+ 4.9 %
- 0.2 %
+ 7.1 %
+ 13.3 %
- 6.2 %
- 1.4 %
+ 16.0 %
Net Asset Value
169.94 CHF
Asset Under Management
629 M €
Net Equity Exposure30/06/2025
32.9 %
SFDR - Fund Classification
Article 8
Portfolio Composition
Discover the Fund's portfolio and allocation to get an overview of the distribution of its investments, to better understand its strategy, diversification and risk exposure.
Key figures
Below are some key figures to help you understand the Fund's management and positioning.Exposure Data
Data as of: Jun 30, 2025.Net Equity Exposure32.9 %
Beta+0.1 %
Sortino Ratio0.0
Number of Holdings21
To Access the weekly view
TOP 10 Fund Positions
The main positions of Fund are classified according to their weighting and expressed as a percentage of the Fund's total assets.Top Ten - Equities
Data as of: Jun 30, 2025.| FRESENIUS SE & CO KGAA |  Germany | Healthcare | 9.0% |
| SAP SE | Germany | Information Technology | 8.2% |
| MICROSOFT CORP |  USA | Information Technology | 7.2% |
| PRADA SPA |  Italy | Consumer Discretionary | 5.2% |
| PROSUS NV |  China | Consumer Discretionary | 4.8% |
| TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD |  Taiwan | Information Technology | 4.4% |
| ASM INTERNATIONAL NV |  Netherlands | Information Technology | 4.4% |
| ASR NEDERLAND NV | Netherlands | Financials | 4.2% |
| AIR LIQUIDE SA |  France | Materials | 4.1% |
| UNITEDHEALTH GROUP INC | USA | Healthcare | 3.7% |
Total
55.3 %
To Access the weekly view
Top 10 Short Positions
Data as of: Jun 30, 2025. United Kingdom | Consumer Discretionary | -2.2% |
| USA | Communication Services | -2.1% |
 Luxembourg | Consumer Staples | -1.9% |
 Switzerland | Healthcare | -1.9% |
 Sweden | Real Estate | -1.9% |
 Denmark | Healthcare | -1.7% |
| France | Consumer Discretionary | -1.6% |
| France | Industrials | -1.4% |
| USA | Industrials | -1.2% |
Total
-16.1 %
To Access the weekly view
Geographical Breakdown
The Fund’s exposure to specific country and region provides you with an insight on its diversification as well as the opportunities and risks involved. The geographic breakdown also provides an overview of the Fund's investment strategy and current positioning.Geographical Breakdown
Data as of: Jun 30, 2025.| North America | 23.9 % | -13.0 % | 11.0 % |
| Others | 12.8 % | - | 12.8 % |
| Europe EUR | 52.8 % | -15.8 % | 37.0 % |
| Europe ex-EUR | 14.2 % | -17.1 % | -3.0 % |
| Index Derivatives | 2.9 % | -27.8 % | -24.9 % |
North America11.0 %
 Canada | - | -0.7 % |
| USA | 23.9 % | -12.3 % |
To Access the weekly view
Sector Breakdown
The Fund’s exposure to specific sector provides you with an insight on its diversification as well as the opportunities and risks involved. The sector breakdown also provides an overview of the Fund's investment strategy and current positioning.
Equity Exposure
The chart displays the proportion of the Fund's assets invested in equities and how this exposure has changed over time. It enables investors to understand the level of risk associated with the Fund and whether the asset allocation is in line with the Fund’s risk framework.Equity Exposure (% of total AUM)
Data as of: Jun 30, 2025.- Equity Investment Rate
- Equity Exposure
Capitalisation Breakdown
The capitalisation breakdown refers to the distribution of the Fund's investments according to the size of the companies in which it invests. It indicates in which capitalisation categories (small, medium or large) the Fund allocates its capital.Equity Derivatives
This table lists all the equity derivatives in the portfolio. It shows the underlying assets to which the fund is exposed and the fund's position (long or short) on each of these underlyings.Equity Derivatives
Data as of: Jul 4, 2025.| Equity derivatives | ||
| EURO STOXX 50 PR | ||
| RUSSEL 2000 INDEX | ||
| STXE 600 € PR | ||
| STXE 600 INS € PR |
Total (Long + Short)
-18.5 %
Related articles
Alternative Strategy • November 14, 2024 • English
Carmignac Portfolio Long Short European Equities: Letter from the Fund Manager
2 minute(s) read
Alternative Strategy • August 22, 2024 • English
Carmignac Portfolio Long-Short European Equities: Letter from the Fund Manager
Alternative Strategy • May 14, 2024 • English
Carmignac Portfolio Long-Short European Equities: Letter from the Fund Manager
3 minute(s) read
Did you enjoy the fund page?
Carmignac Gestion Luxembourg SA in its capacity as the Management Company for Carmignac Portfolio, has delegated the investment management of this Sub-Fund to White Creek Capital LLP (Registered in England and Wales with number OCC447169) from 2nd May 2024. White Creek Capital LLP is authorised and regulated by the Financial Conduct Authority with FRN : 998349.
The reference to a ranking or prize, is no guarantee of the future results of the UCIS or the manager.
Carmignac Portfolio is a sub-fund of Carmignac Portfolio SICAV, an investment company under Luxembourg law, conforming to the UCITS Directive.
The information presented above is not contractually binding and does not constitute investment advice. Past performance is not a reliable indicator of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor), where applicable. Investors may lose some or all of their capital, as the capital in the UCI is not guaranteed. Access to the products and services presented herein may be restricted for some individuals or countries. Taxation depends on the situation of the individual. The risks, fees and recommended investment period for the UCI presented are detailed in the KIDs (key information documents) and prospectuses available on this website. The KID must be made available to the subscriber prior to purchase.). The reference to a ranking or prize, is no guarantee of the future results of the UCITS or the manager.